Rigvir holding is the manufacturer of unique cancer medicine, which is able to find and destroy malignant tumour cells in the human body. This kind of cancer treatment, called oncolytic virotherapy, is evidence based and recognised as safe and effective therapy. Rigvir holding unites a group of companies whose activities are focused on production and development of oncolytic virotherapy cancer medicine.
| Website | http://rigvir.com |
| Revenue | $6.6 million |
| Employees | 2 (1 on RocketReach) |
| Founded | 2003 |
| Address | 9-7 Teatra St, Riga LV-1050, LV |
| Phone | +371 67 716 132 |
| Technologies |
HTML
,
Google Analytics
,
Bootstrap
+9 more
(view full list)
|
| Industry | Pharmaceuticals, Manufacturing General, Health Care, Marketing and Advertising, Manufacturing, Medical, Pharmaceutical |
| Keywords | Cancer Medicine, Targeted Cancer Therapy, Cancer Treatment, Oncolytic Virus, Immunotherapy, Evidence Based Medicine, Cancer Research, Clinical Trials, Pharmaceutical Research, Biotechnology, Drug Development, Medicine Manufacturing, Health Care |
| Competitors | Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, Oncolytics Biotech Inc. +35 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular RIGVIR Holding employee's phone or email?
RIGVIR Holding Questions
The RIGVIR Holding annual revenue was $6.6 million in 2026.
Jurgis Auzins is the Founder of RIGVIR Holding.
1 people are employed at RIGVIR Holding.
The NAICS codes for RIGVIR Holding are [3254, 325, 32, 32541].
The SIC codes for RIGVIR Holding are [28, 283].
Top RIGVIR Holding Employees
-
Jurgis Auzins
Founder at RIGVIR Holding
London, England, GB
Related Companies
